Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

E56: Unrealistic Timelines in a Cancer Diagnosis

E56: Unrealistic Timelines in a Cancer Diagnosis

FromThe Eye Believe Podcast


E56: Unrealistic Timelines in a Cancer Diagnosis

FromThe Eye Believe Podcast

ratings:
Length:
11 minutes
Released:
Jan 27, 2023
Format:
Podcast episode

Description

Join Danet, the Eye Believe Podcast Host, to discuss unrealistic timelines in a cancer diagnosis. Can you relate!?

Make sure to share this episode with another omie today, and if you’re able, make a small donation to keep our podcast going!
 
ANNOUNCEMENTS:

Steps for Sight Registration is open! It’s not to late to join us this month!

www.charityfootprints.com/SFS

Eye on Mental Health 2023 is now open for registration! Head to the site below to register!
 
Register at https://tinyurl.com/eyeonmentalhealth23

Subscribe to the newsletter to stay in the know

Newsletter link
 
Email contact@acureinsight.org for questions regarding any upcoming events!

*********
Be sure to follow us on Facebook, Twitter, Linked In, or  Instagram @acureinsight, for more stories, tips, research news, and ideas to help you navigate this journey with OM!
*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more!

Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure.

Contribute via  PAYPAL OR VENMO or reach out directly to contact@acureinsight.org 
The Eye Believe Podcast is brought to you by Castle Biosciences. Castle Biosciences is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors. 
This podcast was hosted by Danet Peterson and produced by Page Fronczek.
 
Released:
Jan 27, 2023
Format:
Podcast episode

Titles in the series (100)

Sharing information and insights on treatment, research, and living with ocular melanoma.